Search

everythinglearnresearchcommunity

for

Search:↓

Intratesticular PRP injections are safe but not proven to improve sperm retrieval in certain infertile men.

Medical treatments for benign prostatic hyperplasia mainly relieve symptoms, while surgery is more effective but not always suitable for elderly patients.

Nanotechnology therapies can help improve quality of life for those with hair loss.

The document concludes that non-endocrine alopecia in pets varies in treatment effectiveness and often has a poor prognosis, especially in cats.

Gender identity can be more diverse than just male or female.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Some birth control pills have a higher risk of blood clots than others.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

High-dose radioactive iodine therapy does not harm fertility in thyroidectomy patients.

VDR gene variations may affect carbohydrate metabolism in young women with hyperandrogenism.

Both steroids, especially cyproterone acetate, harm quail's vital organs.

The alexandrite laser effectively reduces unwanted hair by about 75%.

Androgenetic alopecia with telogen effluvium is the most common hair loss in women with hirsutism.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Minoxidil and finasteride work best for hair loss; more research needed.

Estrogens and progesterone are key in regulating melasma pigmentation.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

New acne treatments show promise as alternatives to traditional therapies.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.